HARTFORD, Conn. (WTNH) A Hartford Healthcare neurologist is cautiously excited about a new treatments ability to prevent memory loss in patients with Alzheimers disease.<\/p>\n
Dr. Amy Sanders has been watching research indicating that the drug lecanemab can either slow or altogether stop cognitive decline. <\/p>\n
The results, she said, werent surprising.<\/p>\n
That has been the Holy Grail of Alzheimers disease pharmaceutical research for decades, so this is the first time my heart went pitty pat, when I read these announcements, Sanders said. <\/p>\n
Lecanemab clears amyloid plaques, which are protein deposits linked to dementia. <\/p>\n
Weve had agents that could clear amyloid plaques in the past, but we have not had the one-two punch, Sanders said. And its possible that we now have it.<\/p>\n
The 1,800 people in the clinical trial had either a mild form of Alzheimers disease, or a pre-Alzheimers condition that is considered to be a mild cognitive impairment.<\/p>\n
While the data wont be released until the end of November, the Alzheimers Association has called the study a major development, and said that more drugs are in the pipeline.<\/p>\n
<\/p>\n
See the rest here: HARTFORD, Conn. (WTNH) A Hartford Healthcare neurologist is cautiously excited about a new treatments ability to prevent memory loss in patients with Alzheimers disease. Continue reading
\nHartford Healthcare neurologist excited about possible new Alzheimers disease treatment - WTNH.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"